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a degree of stent expansion comparable to that with intravascular ultrasound (IVUS) guidance.
BACKGROUND The most important predictor of adverse outcomes (thrombosis and restenosis) after stent implanta-
tion with IVUS guidance is the degree of stent expansion achieved.
METHODS We compared the relative degree of stent expansion (deﬁned as the minimal stent area divided by the mean
of the proximal and distal reference lumen areas) after OCT-guided stenting in patients in the ILUMIEN (Observational
Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous
Coronary Intervention) (N ¼ 354) and IVUS-guided stenting in patients in the ADAPT-DES (Assessment of Dual Anti-
platelet Therapy With Drug-Eluting Stents) study (N ¼ 586). Stent expansion was examined in all 940 patients in a
covariate-adjusted analysis as well as in 286 propensity-matched pairs (total N ¼ 572).
RESULTS In the matched-pair analysis, the degree of stent expansion was not signiﬁcantly different between OCT and
IVUS guidance (median [ﬁrst, third quartiles] ¼ 72.8% [63.3, 81.3] vs. 70.6% [62.3, 78.8], respectively, p ¼ 0.29).
Similarly, after adjustment for baseline differences in the entire population, the degree of stent expansion was also not
different between the 2 imaging modalities (p ¼ 0.84). Although a higher prevalence of post-PCI stent malapposition,
tissue protrusion, and edge dissections was detected by OCT, the rates of major malapposition, tissue protrusion, and
dissections were similar after OCT- and IVUS-guided stenting.
CONCLUSIONS In the present post-hoc analysis of 2 prospective studies, OCT and IVUS guidance resulted in a com-
parable degree of stent expansion. Randomized trials are warranted to compare the outcomes of OCT- and IVUS-guided
coronary stent implantation. (J Am Coll Cardiol Intv 2015;8:1704–14) © 2015 by the American College of Cardiology
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AB BR E V I A T I O N S
AND ACRONYM S
CSA = cross-sectional area
DS = diameter stenosis
EEM = external elastic
membrane
IVUS = intravascular
ultrasound
MLD = minimal lumen diameter
MSA = minimal stent area
OCT = optical coherence
tomography
PCI = percutaneous coronary
intervention
QCA = quantitative coronary
angiography
RVD = reference vessel
diameter
STEMI = ST-segment elevation
myocardial infarction
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1705B y intravascular ultrasound (IVUS) imaging,the strongest predictor of early stent throm-bosis and restenosis is the absolute degree
of stent expansion as assessed by the minimal stent
area (MSA) after percutaneous coronary interven-
tion (PCI) (1–6). By achieving greater stent expan-
sion, IVUS guidance has been associated with
improved event-free survival compared with angio-
graphic guidance alone (7–9). Optical coherence to-
mography (OCT) has superior resolution compared
with IVUS (10,11), but in many cases, the limited
penetration depth of OCT prevents visualization of
the vessel size (external elastic membrane [EEM]),
a key parameter used during IVUS-guided stent
sizing. Whether routine OCT guidance results in a
degree of stent expansion comparable to that with
IVUS guidance is unknown. We therefore compared
the degree of stent expansion achieved after OCT
and IVUS guidance in 2 large-scale, prospective
studies, the ILUMIEN I (Observational Study of Op-
tical Coherence Tomography [OCT] in Patients Un-
dergoing Fractional Flow Reserve [FFR] and
Percutaneous Coronary Intervention) study and the
ADAPT-DES (Assessment of Dual Antiplatelet Ther-
apy With Drug-Eluting Stents) study.
METHODS
STUDY DESIGN AND ENDPOINTS. The present study
(ILUMIEN II) was designed as a post-hoc analysis of
the outcomes of OCT- versus IVUS-guided stent im-
plantation from the prospectively performed, multi-
center ILUMIEN I and ADAPT-DES studies. The study
protocol and statistical analyses were speciﬁed
before data analysis. The study ﬂow is shown in
Figure 1. Patients in whom bare metal or drug-eluting
stents (but not bioresorbable scaffolds) were implan-
ted in a native coronary artery in which post-PCI OCT
or IVUS was performed and analyzed at an indepen-
dent core laboratory were considered for inclusion.
Patients with left main coronary artery, saphenous
vein graft, in-stent restenosis, or chronic total
occlusion stented lesions were excluded, as were ST-
segment elevation myocardial infarction (STEMI) pa-
tients and patients in whom the reference segment
could not be measured.
The primary endpoint was the ﬁnal post-PCI stent
expansion deﬁned as the MSA divided by the mean ofBoston Scientiﬁc, and Volcano Corporation. Dr. Shite has received consultin
the advisory board of Volcano Corporation. Dr. Stone is a former consultant
have reported that they have no relationships relevant to the contents of th
Manuscript received July 22, 2015; accepted July 30, 2015.the proximal and distal reference lumen areas
as assessed by OCT in the ILUMIEN I and by
IVUS in the ADAPT-DES (1,12,13). This relative
measure of stent expansion was used in
preference to absolute MSA because IVUS
measurements are typically larger than those
by OCT (13–15). Major secondary endpoints
included mean stent expansion deﬁned as
the mean stent volume divided by the mean
reference lumen area and post-PCI in-stent
and in-segment percentage of diameter ste-
nosis (DS) measured by quantitative coronary
angiography (QCA), both of which are inde-
pendent of an intravascular imaging modal-
ity. Additional endpoints included in-stent
and in-segment acute gain and minimal
lumen diameter (MLD) by QCA and the prev-
alence of major stent malapposition, tissue
protrusion, and edge dissections identiﬁed by
IVUS or OCT, as deﬁned in the following.ILUMIEN I AND ADAPT-DES. ILUMIEN I was a pro-
spective, multicenter study performed in 418 patients
at 36 centers in the United States, Canada, European
Union, Australia, and Asia designed to identify OCT
stent parameters related to 1-year outcomes after PCI
in de novo coronary artery lesions (16). Patients with
stable angina, unstable angina, or non-STEMI having
at least 1 lesion with angiographic DS >50% by visual
estimation were enrolled. As many as 3 lesions in 2
vessels could be treated, but no more than 2 lesions
per vessel. Fractional ﬂow reserve and OCT were
performed pre-PCI and post-PCI. If OCT assessment
post-PCI was deemed unsatisfactory (ﬂow-limiting
edge dissection or tissue/thrombus protrusion, mal-
apposition >0.2 mm, or stent expansion #70%
compared with the distal reference lumen area and
with an angiographic DS >20%), further optimization
was recommended, and repeat OCT imaging per-
formed. Only the ﬁnal OCT image was assessed in the
present study.
ADAPT-DES was previously described in detail (17).
Brieﬂy, ADAPT-DES was a prospective, multicenter
registry of an “all-comers” population of 8,582
patients at 13 U.S. and German centers to deter-
mine the relationship between platelet reactivity and
subsequent stent thrombosis through 2-year follow-
up after successful drug-eluting stent implantation.g fees from St. Jude Medical. Dr. Witzenbacher is on
for Boston Scientiﬁc and Infraredx. All other authors
is paper to disclose.
FIGURE 1 Enrollment, Exclusion, and Final Cohorts
In ILUMIEN I, 354 of 418 enrolled patients were included in the current study population. In
ADAPT-DES, 586 of 2,179 patients enrolled in the IVUS substudy were included in the
current study population. From these 940 patients, 286 propensity-matched groups were
created. Note: QCA was not routinely performed in ADAPT-DES, but was completed in a
subset of patients in the IVUS substudy (9). Reasons for exclusion were not mutually
exclusive. IVUS ¼ intravascular ultrasound; QCA ¼ quantitative coronary angiography;
STEMI ¼ ST-segment elevation myocardial infarction.
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1706Decisions whether and how to use IVUS were per
operator discretion, although IVUS use was encour-
aged. The relationship between ﬁnal IVUS parameters
and clinical outcomes was determined in a pre-
speciﬁed substudy of 2,179 patients (9).
Both ILUMIEN I and ADAPT-DES were approved by
the institutional review board at each participating
center, and all participating patients signed written
informed consent.
OCT AND IVUS IMAGING AND ANALYSIS. In the
ILUMIEN I study, immediately after intracoronary
nitroglycerin administration, an OCT catheter (C7
Dragonﬂy, Dragonﬂy, Duo or Dragonﬂy JP, St. Jude
Medical, St. Paul, Minnesota) was introduced distal to
the stented lesion, and contrast media was injected
via the guiding catheter during pull back. A C7XR,
ILUMIEN, or ILUMIEN OPTIS OCT imaging system
(St. Jude Medical) was used for OCT image acquisition
at 100 or 180 frames/s at a pull-back speed of 10 to 25
mm/s.
In the ADAPT-DES IVUS substudy, gray-scale IVUS
was performed after administration of intracoronary
nitroglycerin using a synthetic aperture array, 20
MHz, 3.2-F catheter (Eagle Eye, Volcano Corporation,
Rancho Cordova, California) and an s5 console (Vol-
cano Corporation). The IVUS catheter was advanceddistal to the lesion and pulled backed at 0.5 mm/s to
the aorto-ostial junction using the R-100 motorized
catheter pull-back system (Volcano Corporation).
OCT AND IVUS ANALYSIS AND DEFINITIONS.
Final post–stent placement OCT images were recor-
ded digitally and analyzed ofﬂine using proprietary
software (St. Jude Medical) at independent core lab-
oratories (University Hospitals Imaging Core Labora-
tory, Cleveland, Ohio, and the Cardiovascular
Research Foundation, New York, New York). Initial
analyses performed at the University Hospitals’ core
laboratory were reassessed at the Cardiovascular
Research Foundation core laboratory, and additional
analyses were performed. Quantitative OCT mea-
surements were done for all available slices including
the lesion and 5-mm-long proximal and distal refer-
ence segments; stent measurements were done every
1 mm within the stent (10,11). Similarly, ﬁnal post-
stent, ofﬂine IVUS analyses were performed using
computerized planimetry software (echoPlaque,
INDEC Systems Inc., Santa Clara, California), at an
independent IVUS core laboratory (Cardiovascular
Research Foundation). Quantitative IVUS measure-
ments were performed every 1 mm of the stented
lesion including 5-mm-long proximal and distal
reference segments (1–6).
For both IVUS and OCT, the slices with the minimal
lumen cross-sectional area (CSA), the MSA within
each lesion, and the smallest and largest lumen CSA
within each reference segment were identiﬁed and
assessed (Figure 2). Total and normalized volumes
(volume divided by analysis length) were determined
using Simpson’s rule. The percentage of stent or
lumen expansion was deﬁned as MSA or minimal
lumen CSA divided by the mean of the largest prox-
imal and distal reference lumen CSAs. The percentage
of mean stent or lumen expansion was deﬁned as the
mean stent or lumen CSA divided by the mean of the
proximal and distal reference largest lumen CSAs. In
lesions having only 1 reference (proximal or distal;
e.g., a lesion abutting a bifurcation), the single
reference lumen area was used.
The core laboratory also assessed the degree of
intrastrut tissue protrusion (plaque and/or thrombus
protrusion through stent struts into the lumen), stent
malapposition (space behind stent struts not over-
lying a side branch), and edge dissection (intimal or
medial dissection, intramural hematoma, or dissec-
tion outside of the media) (Figure 3) (5,10,11,15,18,19).
Malapposition was considered major if the malap-
position distance was >20% of the mean lumen
diameter, equivalent to w2.5 mm2 or 35% malap-
position CSA (malapposition CSA divided by the
FIGURE 2 Examples of Post-Stent Quantitative Measurements by OCT and IVUS
(Left) In the OCT example, the minimal stent area measured 7.70 mm2, and the largest proximal and distal lumen areas measured 8.02 mm2 and 6.96 mm2, respectively,
for a mean reference lumen area of 7.49 mm2. Stent expansion was calculated to be 103%. (Right) In the IVUS example, the minimal stent area measured 7.2 mm2,
and the largest proximal and distal lumen areas measured 11.1 mm2 and 8.1 mm2, respectively, for a mean reference lumen area of 9.6 mm2. Therefore, stent
expansion was calculated to be 75%.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 3 , 2 0 1 5 Maehara et al.
N O V E M B E R 2 0 1 5 : 1 7 0 4 – 1 4 OCT vs. IVUS and Stent Expansion
1707lumen CSA), assuming a 3-mm lumen diameter or a
7-mm2 lumen CSA. Tissue protrusion was considered
major if the percentage of tissue protrusion (tissue
protrusion CSA divided by stent CSA) was >10%.
Dissection was considered major when the measured
length of the dissection was $3 mm (5,10,11,18,19).FIGURE 3 Examples of Post-stent Qualitative Findings by OCT and I
OCT images (top) and IVUS images (bottom) from different cases. Mala
struts and plaque surface. Tissue protrusion appeared as protruding tissue
appeared as a ﬂap of tissue separated from the media.QUANTITATIVE CORONARY ANGIOGRAPHY. Coronary
angiograms from both ILUMIEN I and ADAPT-DES
were analyzed at the angiographic core laboratory of
the Cardiovascular Research Foundation using
Medis Medical Imaging Systems software (QAngio
XA 7.2, Leiden, the Netherlands). In-segment analysisVUS
pposition appeared as ﬂoating stent struts with space between the
through the stent struts into the lumen. Medial stent edge dissection
TABLE 1 Baseline Characteristics and Procedures in the Propensity-Matched Groups
OCT
(N ¼ 286)
IVUS
(N ¼ 286) p Value
Patient characteristics
Age, yrs 66.0 (58.0, 72.0) 67.0 (59.0, 72.0) 0.97
Male 213 (74.5) 213 (74.5) 1.0
Diabetes mellitus 104/285 (36.5) 79/285 (27.7) 0.03
Current or former smoker 138/285 (48.4) 147/285 (51.6) 0.44
History of renal insufﬁciency 18/285 (6.3) 27/285 (9.5) 0.17
Previous myocardial infarction 70/283 (24.7) 63/283 (22.3) 0.49
Body mass index, kg/m2 27.0 (24.2, 30.5) 26.9 (24.8, 29.4) 0.76
Clinical presentation
Non-STEMI 29 (10.1) 65 (22.7) <0.0001
Unstable angina 63 (22.0) 47 (16.4) 0.10
Stable coronary artery disease 194 (67.8) 174 (60.8) 0.09
Target vessel
Left anterior descending 178 (62.2) 126 (44.1) <0.0001
Left circumﬂex 53 (18.5) 81 (28.3) 0.005
Right coronary 55 (19.2) 79 (27.6) 0.02
Procedural information
Drug-eluting stent implantation 282/285 (98.9) 284/285 (99.6) 0.63
Total stent length, mm 18.0 (15.5, 28.0) 23.0 (15.0, 32.0) 0.01
Maximal device diameter, mm* 3.0 (2.8, 3.5) 3.0 (3.0, 3.5) <0.0001
Maximal device/artery diameter ratio 1.1 (1.0, 1.2) 1.2 (1.1, 1.3) 0.002
Values are median (ﬁrst, third quartiles), n (%), or n/N (%). *Either balloon or stent.
IVUS ¼ intravascular ultrasound; OCT ¼ optical coherence tomography; STEMI ¼ ST-segment elevation
myocardial infarction.
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1708included the stent plus 5-mm proximal and distal
reference segments. Quantitative and qualitative an-
alyses were done using standard methods (20). QCA
was speciﬁed in all patients from the ILUMIEN I study
and was performed in 1,136 patients from the ADAPT-
DES IVUS substudy.
STATISTICAL ANALYSIS. If multiple lesions were
treated, 1 lesion was randomly chosen for analysis.
The effect of OCT versus IVUS on stent expansion
and other parameters was examined in 2 ways:
by analysis of propensity-matched pairs and in a
covariate-adjusted analysis using all patients. Paired
matched groups (IVUS vs. OCT) were created adjust-
ing for 4 confounders that may affect the degree of
stent expansion or its measurement: the extent of
angiographic calciﬁcation (severe, moderate, mild/
none); QCA lesion length; QCA reference vessel
diameter (RVD); and whether both or only a single
reference site (proximal and/or distal) were available
for calculation of stent expansion. Regarding the
latter, an OCT lesion with both references was
matched with a corresponding IVUS lesion with both
references, whereas an OCT lesion with only a prox-
imal or distal reference was matched with a corre-
sponding IVUS lesion with only a proximal or distal
reference, respectively. The subject’s propensity
score was deﬁned as the posterior probability ofeither OCT or IVUS guidance as estimated from a lo-
gistic regression model with the 4 variables as cova-
riates. Matched pairs were created using greedy
matching criteria with a caliper of 0.1. For the second
analysis using the entire study population, the effect
of OCT versus IVUS guidance on the primary and
major secondary endpoints was evaluated by multi-
variable stepwise linear regression (p < 0.2 to enter,
p < 0.1 to stay). Covariates included age, sex,
diabetes, smoking, history of renal insufﬁciency,
previous myocardial infarction, acute coronary syn-
drome presentation, body mass index, left anterior
descending artery (LAD) location, QCA RVD, QCA
MLD, QCA lesion length, the presence of angiographic
moderate or severe calciﬁcation, tortuosity, bifurca-
tion, thrombus, Thrombolysis In Myocardial Infarc-
tion ﬂow, and availability of reference segments by
IVUS or OCT. Imaging modality (OCT vs. IVUS) was
forced into the model.
Categorical variables are presented as frequencies
and were compared by the McNemar test or the exact
McNemar test when <20 discordant pairs. Continuous
variables are presented as medians and ﬁrst and third
quartiles and were compared by a paired Student t
test (when normally distributed per the Shapiro-Wilk
test) or Wilcoxon signed rank test (when not normally
distributed). No formal hypotheses regarding superi-
ority or noninferiority were pre-speciﬁed. All p values
were 2 sided, and p < 0.05 was considered signiﬁcant
for all analyses. Statistical analyses were performed
using SAS version 9.2 (SAS Institute, Cary, North
Carolina).
RESULTS
Study enrollment is shown in Figure 1. A total of 354
of 418 patients enrolled in the ILUMIEN I study, and
586 of 2,179 patients enrolled in the formal IVUS
substudy of ADAPT-DES were included in the present
study. There were no signiﬁcant differences in the
baseline variables between the ILUMIEN I patients
included and those not included (Online Table 1).
There were several baseline differences between the
ADAPT-DES patients included and those not included
(Online Table 2). Of the 940 total study patients, 286
propensity-matched pairs were derived (572 total
patients). Of note, 88.8% of pairs had both proximal
and distal reference segments measured by OCT and
IVUS, 10.5% had only a distal reference, and 0.7% had
only a proximal reference.
MATCHED-PAIR ANALYSIS. The baseline clinical and
angiographic characteristics of the propensity-matched
patients undergoing OCT versus IVUS guidance were
TABLE 2 Quantitative Coronary Angiography Findings in the Propensity-Matched Groups
OCT
(N ¼ 286)
IVUS
(N ¼ 286) p Value
Pre-PCI measurements
Reference vessel diameter, mm 2.7 (2.3, 3.0) 2.7 (2.4, 3.0) 0.17
Minimum lumen diameter, mm 0.9 (0.7, 1.2) 0.9 (0.6, 1.2) 0.12
Diameter stenosis, % 64.3 (57.0, 72.1) 64.0 (56.9, 75.5) 0.03
Lesion length, mm 14.9 (10.9, 21.3) 14.1 (9.8, 23.5) 0.54
Bifurcation lesion 97 (33.9) 93 (32.5) 0.71
Calciﬁcation (moderate or severe) 60 (21.0) 56 (19.6) 0.63
Angulation (moderate or severe) 21 (7.3) 23 (8.0) 0.75
Tortuosity (moderate or severe) 22/283 (7.8) 42/283 (14.8) 0.009
Thrombus present 8 (2.8) 20 (7.0) 0.02
TIMI ﬂow grade 3 257 (89.9) 255 (89.2) 0.78
Worst morphology during PCI
Dissection type B or C* 7 (2.4) 8 (2.8) 1.0
Slow ﬂow or no reﬂow 3 (1.0) 9 (3.1) 0.14
Abrupt closure 2 (0.7) 1 (0.3) 1.0
Perforation 0 (0.0) 3 (1.0) —
Final PCI measurements
Reference vessel diameter, mm 2.6 (2.3, 2.9) 2.7 (2.4, 3.0) 0.12
MLD, mm
In-stent 2.5 (2.3, 2.9) 2.6 (2.3, 2.8) 0.78
In-segment 2.2 (2.0, 2.6) 2.3 (2.1, 2.6) 0.01
In-stent mean lumen diameter, mm 2.9 (2.6, 3.2) 2.9 (2.7, 3.2) 0.76
Diameter stenosis, %
In-stent 6.3 (2.8, 9.6) 6.4 (2.9, 11.9) 0.07
In-segment 13.0 (8.6, 19.8) 12.3 (8.2, 17.3) 0.07
Acute gain, mm
In-stent 1.6 (1.3, 1.9) 1.6 (1.4, 1.9) 0.60
In-segment 1.3 (1.0, 1.6) 1.4 (1.1, 1.7) 0.005
Proximal stent edge MLD, mm 2.8 (2.5, 3.2) 2.8 (2.5, 3.2) 0.046
Distal stent edge MLD, mm 2.3 (2.0, 2.6) 2.4 (2.1, 2.8) <0.0001
Dissection type B* 0 (0.0) 1 (0.4) —
Perforation 0 (0.0) 2 (0.7) —
TIMI ﬂow grade 3 268/278 (96.4) 274/278 (98.6) 0.18
Values are median (ﬁrst, third quartiles) or n (%). *No other dissection type was observed.
MLD ¼minimal lumen diameter; PCI ¼ percutaneous coronary intervention; TIMI ¼ Thrombolysis In Myocardial
Infarction; other abbreviations as in Table 1.
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1709well balanced for the variables expected to affect
stent expansion and measurement: angiographic
moderate/severe calciﬁcation, QCA RVD and lesion
length, and reference segment availability (Tables 1
and 2). Regarding other variables, the OCT cohort
had a slightly higher prevalence of diabetes and LAD
lesion location, whereas non-STEMI, vessel tortuos-
ity, and lesion thrombus were slightly more frequent
in the IVUS cohort.
The primary endpoint of stent expansion was not
signiﬁcantly different between the OCT and IVUS
cohorts (median [ﬁrst, third quartiles]: 72.8% [63.3,
81.3] vs. 70.6% [62.3, 78.8], respectively, p ¼ 0.29)
(Table 3, Figure 4). The major secondary endpoint of
mean stent expansion was also not signiﬁcantly
different (89.6% [79.7, 98.1] vs. 86.2% [76.6, 94.1]
respectively, p ¼ 0.17). However, as expected, abso-
lute IVUS area measurements were systematically
larger than OCT area measurements.
As shown in Table 4, and also as expected, any
stent malapposition, tissue protrusion, and stent
edge dissection were detected in a substantially
greater proportion of OCT cases compared with IVUS.
However, the prevalence of major malapposition,
major tissue protrusion, major edge dissection, and
intramural hematoma were infrequent and not sig-
niﬁcantly different between groups.
The major QCA secondary endpoints of post-PCI in-
stent and in-segment DS were not signiﬁcantly
different with OCT versus IVUS guidance, although
the MLD at the stent edges (in-segment) was slightly
smaller in the OCT group (Table 2). Severe complica-
tions such as no reﬂow, abrupt closure, and perfora-
tion were uncommon in both groups.
ENTIRE STUDY POPULATION ANALYSIS. As shown
in Online Tables 3 and 4, there were substantial dif-
ferences in baseline clinical and angiographic char-
acteristics between the unmatched groups. By
multivariable analysis (Table 5), OCT versus IVUS
guidance was not a signiﬁcant predictor of stent
expansion (p¼0.84), mean stent expansion (p¼0.30),
or in-stent QCA DS (p ¼ 0.19). OCT guidance was
signiﬁcantly associated with a greater in-segment DS,
although the difference was small (13.3% [8.9, 20.2] vs.
11.2% [7.6, 17.2], adjusted p ¼ 0.009).DISCUSSION
In the present study, the largest to date to compare the
acute procedural outcomes of OCT- and IVUS-guided
coronary stenting, the relative degree of stent expan-
sion was not signiﬁcantly different with the 2 imaging
techniques. Similarly, OCT and IVUS guidancewere associated with comparable rates of major stent
malapposition, tissue protrusion, and stent edge
dissection.
OCT VERSUS IVUS: QUANTITATIVE COMPARISONS.
By intravascular imaging, the most important deter-
minant of early stent thrombosis and restenosis after
stent implantation is the MSA achieved (1–6).
Whether OCT guidance achieves an MSA comparable
to that with IVUS guidance is unknown. In the pre-
sent study, we compared OCT-measured stent di-
mensions after OCT guidance from the ILUMIEN I
study with IVUS-measured stent dimensions after
IVUS guidance from the ADAPT-DES study. As IVUS
measurements are known to be consistently larger
than OCT measurements (13–15), directly comparing
the MSA achieved in these 2 studies would not
TABLE 3 Quantitative Intravascular Imaging in the Propensity-Matched Groups
OCT
(N ¼ 286)
IVUS
(N ¼ 286) p Value
Stent measurements
Expansion, % 72.8 (63.3, 81.3) 70.6 (62.3, 78.8) 0.29
<90 259 (90.6) 266 (93.0) 0.26
<60 50 (17.5) 54 (18.9) 0.66
<50% 22 (7.7) 14 (4.9) 0.18
Lumen expansion, % 71.1 (62.1, 80.4) 70.0 (61.9, 78.7) 0.40
Mean stent expansion, % 89.6 (79.7, 98.1) 86.2 (76.6, 94.1) 0.17
Mean lumen expansion, % 91.8 (80.9, 99.9) 86.0 (76.9, 93.9) 0.001
Minimal stent CSA, mm2 5.0 (3.9, 6.4) 5.5 (4.4, 7.0) <0.0001
Minimal lumen CSA, mm2 5.0 (4.0, 6.3) 5.5 (4.4, 6.9) <0.0001
Mean stent CSA, mm3/mm 6.4 (5.1, 7.8) 6.7 (5.5, 8.3) <0.0001
Mean lumen CSA, mm3/mm 6.5 (5.3, 7.9) 6.7 (5.5, 8.3) 0.002
Reference measurements, mm2
Proximal reference largest lumen CSA 8.3 (6.2, 10.7) 8.8 (7.1, 11.2) 0.02
Proximal reference minimum lumen CSA 5.6 (4.3, 7.5) 7.4 (5.8, 9.5) <0.0001
Distal reference largest lumen CSA 6.1 (4.7, 7.7) 6.9 (5.3, 9.0) <0.0001
Distal reference minimal lumen CSA 3.9 (2.9, 5.4) 5.8 (4.4, 7.5) <0.0001
Values are median (ﬁrst, third quartiles) or n (%).
CSA ¼ cross-sectional area; other abbreviations as in Table 1.
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1710provide a valid comparison. Therefore, we used the
percentage of stent area expansion (MSA relative to
the reference lumen area) to compare the cross-study
results, which should be technique independent.
With this approach, we found the degree of stent
expansion with OCT and IVUS guidance to be com-
parable in the propensity-matched pair analysis, as
well as after multivariable analysis in the entire study
population of 940 patients.
A second measurement technique that we used to
assess acute stent outcomes was QCA, analyzed at
the same core laboratory. Although less sensitive
than intravascular imaging to detect small changes
in stent dimensions, QCA (like relative stent
expansion) is not dependent on the choice of intra-
vascular imaging modality. In this analysis, in-stent
QCA measures of acute gain and post-PCI MLD and
DS were similar after stenting with both intravas-
cular imaging techniques. However, the QCA MLD at
the distal stent edge was signiﬁcantly smaller in the
OCT group compared with the IVUS group, and OCT
was an independent predictor of a greater in-segment
DS compared with IVUS. Of note, although the lesions
were well matched for QCA reference diameter, the
OCT group had more LAD lesions than the IVUS
group, potentially leading to a smaller distal edge
MLD due to greater vessel tapering in LAD vessels
(21). Moreover, the observed QCA differences were
small and of uncertain clinical signiﬁcance.
There are many different approaches to stent
sizing, and a single standardized strategy has notbeen established. Stents can be sized angiographic-
ally, usually w1:1 to the RVD (either by visual
assessment or online QCA), by IVUS sized to the
proximal and/or distal reference lumen dimensions
or to the midwall or to the true vessel dimension
(EEM) at the lesion site, and by OCT, most often
sized to the reference lumen dimensions as the
limited penetration of OCT often precludes EEM
measurement (13). Conversely, some operators size
stents angiographically and then use IVUS or OCT
just to conﬁrm adequate expansion and absence of
other major deﬁciencies (with varying criteria for
what constitutes a suboptimal result requiring
reintervention). There are also differences between
QCA, IVUS, and OCT in how the reference segments
are identiﬁed (which may affect stent length selec-
tion as well as sizing). IVUS studies have shown
that residual plaque burden is an important pre-
dictor of stent edge restenosis, and as such, inter-
mediate disease segments should be covered (22).
Although OCT may be unable to assess reference
segment plaque burden, the axial resolution of OCT
is sufﬁciently greater than IVUS (w20 mm vs. 150-
200 mm, respectively) (11–13). The extent to which
these varying factors affect stent length determi-
nation, lesion coverage, and stent expansion with
IVUS versus OCT guidance is uncertain, especially
because these decisions must be made in real time
by interventional operators in the cath lab (not in a
core laboratory).
In this regard, before the present report, only 1
small study compared OCT- and IVUS-guided inter-
vention. Habara et al. (13) randomized 70 de novo
coronary lesions at a single center to OCT- or IVUS-
guided stenting. Good visibility of the vessel wall
was deﬁned as visualization of $270 of the EEM
circumference. Approximately 90% of patients un-
derwent post-dilation after image evaluation revealed
an unsatisfactory result (deﬁned as MSA <90% of
the distal reference lumen area). Post-dilation balloon
size was chosen based on the vessel diameter at the
MSA site if there was good visibility of the EEM
(11% vs. 94% on OCT vs. IVUS, respectively, p< 0.001);
otherwise, post-dilation balloon size was based on
angiography. However, because the vessel wall was
not visible in 89% of the OCT-guided cases, the result
was optimized by angiography. Likely as a result,
MSA and stent expansion (measured by IVUS in both
groups) were smaller after OCT compared with IVUS
guidance (6.1 2.2 mm2 vs. 7.1 2.1 mm2, p¼0.04, and
64.7  13.7% vs. 80.3  13.4%; p¼ 0.002, respectively).
In contrast, the present large-scale, multicenter study
suggests that similar degrees of stent expansion may
be achieved with OCT and IVUS guidance.
FIGURE 4 Cumulative Frequency Distribution of Relative Stent Expansion and Mean Stent Expansion
Cumulative frequency distribution of relative stent expansion (left) and mean stent expansion (right) after OCT guidance (dashed green line)
and IVUS guidance (solid red line). No signiﬁcant differences with OCT and IVUS guidance were found for stent expansion or mean stent
expansion.
TABLE 4 Qualitative Intravascular Imaging in the
Propensity-Matched Groups
OCT
(N ¼ 286)
IVUS
(N ¼ 286) p Value
Presence of stent strut
malapposition
Any malapposition 76 (26.6) 39 (13.6) 0.0002
Distance >0.2 mm 65 (22.7) 38 (13.3) 0.004
Distance/mean lumen
diameter >10%
38 (13.3) 22 (7.7) 0.04
Distance/mean lumen
diameter >20%
4 (1.4) 2 (0.7) 0.69
Distance/mean lumen
diameter >10% and
expansion <60%
8 (2.8) 10 (3.5) 0.81
Presence of tissue protrusion
Any tissue protrusion 182 (63.6) 78 (27.3) <0.0001
Tissue protrusion cross
sectional area >10%
33 (11.5) 23 (8.0) 0.17
Tissue protrusion >10%
and expansion <60%
10 (3.5) 6 (2.1) 0.45
Presence of stent edge
dissection
Any dissection 66 (23.1) 15 (5.2) <0.0001
Intimal dissection 27 (9.4) 3 (1.0) <0.0001
Medial dissection 40 (14.0) 7 (2.4) <0.0001
Intramural hematoma 2 (0.7) 5 (1.7) 0.45
Dissection with arc $60 14 (4.9) 5 (1.7) 0.04
Dissection with length$3 mm 7 (2.4) 3 (1.0) 0.29
Proximal stent edge
location
3 (1.0) 0 (0.0) —
Distal stent edge location 4 (1.4) 3 (1.0) 1.0
Values are n (%).
Abbreviations as in Table 1.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 3 , 2 0 1 5 Maehara et al.
N O V E M B E R 2 0 1 5 : 1 7 0 4 – 1 4 OCT vs. IVUS and Stent Expansion
1711OCT VERSUS IVUS: QUALITATIVE COMPARISONS.
Due to its higher resolution, stent malapposition,
tissue prolapse, and edge dissections are detected
more commonly by OCT than IVUS (14,15,23) For
example, Kubo et al. (15) reported greater rates of
stent malapposition (39% vs. 14%; p < 0.001), tissue
protrusion (95% vs. 18%; p < 0.001), intrastent
thrombus (13% vs. 0%; p ¼ 0.01), and stent edge
dissections (13% vs. 0%; p ¼ 0.001) with OCT
compared with IVUS imaging. However, many of
these abnormalities are small and of uncertain clin-
ical relevance. Several studies have demonstrated
that acute stent malapposition is not a risk factor for
stent thrombosis or restenosis unless accompanied
by a small MSA (18,19,24). Similarly, in an IVUS
study of 389 patients undergoing primary PCI for
STEMI, tissue protrusion was unrelated to stent
thrombosis as long as the residual lumen area was
sufﬁcient (5). In a study of 249 post-stent lesions
evaluated by OCT, edge dissections were found in
37.8% of lesions, 84% of which were not visible on
angiography (23). Additional stents were implanted
in 22.6% of these lesions at operators’ discretion, and
1-year outcomes were similar in lesions with and
without untreated edge dissection. Conversely, in
other studies, large edge dissections detected by IVUS
have been related to both early stent thrombosis and
restenosis (5). In our study, OCT detected many more
cases of acute stent malapposition, tissue prolapse,
and edge dissection than IVUS, likely due to its supe-
rior resolution. However, the rates of major malap-
position, tissue prolapse, and edge dissection, which,
as deﬁned, would be expected to be detected with
TABLE 5 Multivariable Analysis in the Entire Study Population (N ¼ 940)
Endpoints
Stent Expansion, %
Mean Stent
Expansion, %
Diameter Stenosis
In-Stent, %
Diameter Stenosis
In-Segment, %
Measurement by
OCT (N ¼ 354)
72.6 (63.5, 81.4) 89.6 (79.2, 98.5) 6.4 (2.7, 9.9) 13.3 (8.9, 20.2)
Measurement by
IVUS (n ¼ 586)
70.5 (62.1, 79.5) 86.8 (77.1, 96.8) 6.4 (3.0, 10.7) 11.2 (7.6, 17.2)
Adjusted p Values
OCT vs. IVUS
guidance
0.84 0.30 0.19 0.009
Age 0.04 * * *
Previous
myocardial
infarction
* * 0.04 *
Lesion length <0.0001 0.0009 <0.0001 *
Reference vessel
diameter
* 0.07 * 0.04
Bifurcation lesion 0.0006 * * 0.07
Tortuosity
(moderate or
severe)
0.01 * * *
Calciﬁcation
(moderate or
severe)
* 0.0007 * *
Left anterior
descending
location
* * 0.02 *
Reference
availability
<0.0001 <0.0001 * *
Values are median (ﬁrst, third quartiles) unless otherwise indicated. *p > 0.1 and thus not selected in the ﬁnal
model. OCT vs. IVUS was forced into the multivariable model.
Abbreviations as in Table 1.
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comparable in the 2 groups and were infrequent.
STUDY LIMITATIONS. The present study is a non-
randomized, retrospective comparison from 2 sepa-
rate registries with different operators at different
centers. However, both ILUMIEN I and ADAPT-DES
were carefully controlled, prospective, multicenter
studies, and all IVUS, OCT and QCA images were
assessed at the same core laboratory, ensuring
standardized assessment techniques. Nonetheless,
differences in baseline clinical features and angio-
graphic measures between the study groups were
evident. There were substantial imbalances in the
regional distribution of enrollment in the current
study: all of the patients in the ADAPT-DES cohort
were enrolled from German sites (N ¼ 586), whereas
the ILUMIEN I cohort included 124 patients (35.0%)
from multiple North American sites, 118 patients
(33.3%) from multiple European sites, and 112 pa-
tients (31.6%) from multiple Asian sites. The impact
of different regional practice patterns on technique
and therefore image-guided stenting should be
explored in a large-scale, multicenter, internationalrandomized trial. Moreover, QCA was only performed
in 48% of the 2,179 patents in the ADAPT-DES IVUS
substudy, introducing potential selection bias. There
are also fundamental differences in the manner in
which IVUS and OCT images are acquired and
measured. For example, the resolution with the
20-MHz IVUS catheter is w10% of that with OCT,
there are differences in pull-back speeds between
IVUS and OCT (and the IVUS pull back is less accu-
rate), and OCT measurements do not take into
consideration the cardiac cycle. For the entire cohort
(OCT, N ¼ 354; IVUS, N ¼ 586), the prevalence of pre-
intervention imaging was 57.7% for IVUS and 93.7%
for OCT (p < 0.0001). Pre-intervention imaging may
affect device sizing and thus stent expansion. We
therefore cannot rule out the inﬂuence of unmea-
sured confounders, although the major determinants
of stent expansion were controlled for either in the
matching process or by multivariable analysis.
Second, neither study speciﬁed the method of
stent sizing or criteria for optimal stent implanta-
tion; thus, the generalizability of these ﬁndings is
uncertain. Third, whether relative stent expansion is
as good a predictor of long-term outcomes as is the
absolute MSA is not entirely clear (1–6,25). Stent
expansion measurements may also be less precise in
long, tapering lesions. However, total stent length in
the current study was relatively short (w20 mm) and
therefore less likely to affect the ﬁnal results.
Fourth, in w10% of cases, both reference segments
could not be measured and were excluded. Fifth,
multiple lesions were present in 7.3% of ILUMIEN I
patients and in 15.8% of ADAPT-DES patients. The
protocol pre-speciﬁed that in patients with multiple
lesions, only 1 lesion per patient would be randomly
chosen and analyzed before matching. Given the
relatively low frequency of multiple lesions, it is
unlikely that the results would have been materially
changed had all lesions had been analyzed. Sixth,
procedural data, such as inﬂation pressure, was not
available in ILUMIEN-I, precluding a complete com-
parison of procedural factors. Finally, long-term
outcome data are not yet available from ILUMIEN I,
and the present study was not designed to determine
clinical differences between OCT- and IVUS-guided
stent implantation. Prati et al. (12) retrospectively
compared 335 OCT-guided PCI cases with 335
propensity-matched angiography-guided PCI cases.
OCT guidance was associated with a lower risk of
cardiac death or MI (odds ratio: 0.49 [0.25, 0.96],
p ¼ 0.04) after adjustment for clinical and procedural
factors. However, the rate of death at 1 year in the
angiography-guided group was unexpectedly high
(6.9%), raising the possibility of play of chance.
PERSPECTIVE
WHAT IS KNOWN? By achieving greater stent expan-
sion, IVUS guidance has been associated with improved
event-free survival compared with angiographic guidance
alone.
WHAT IS NEW? In this study, OCT guidance showed a
similar degree of stent expansion compared with IVUS
guidance.
WHAT IS NEXT? Further studies are warranted to determine
whether OCT and IVUS guidance can be translated into improved
long-term outcomes compared with angiographic guidance
alone.
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1713CONCLUSIONS
The present study suggests that OCT guidance may
achieve a comparable degree of stent expansion as
that with IVUS guidance, with a similarly low fre-
quency of major stent malapposition, tissue prolapse,
and edge dissections. Randomized studies are thus
warranted to determine whether similar clinical out-
comes are obtained after stenting guided by these
2 intravascular imaging modalities.
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